Susan W Wesmiller1, Catherine M Bender2, Susan M Sereika3, Gretchen Ahrendt4, Marguerite Bonaventura4, Dana H Bovbjerg5, Yvette Conley6. 1. School of Nursing, University of Pittsburgh in Pennsylvania. 2. School of Nursing and the Department of Clinical Translational Science, University of Pittsburgh in Pennsylvania. 3. Department of Clinical Translational Science, and the Graduate School of Public Health, University of Pittsburgh in Pennsylvania. 4. School of Medicine, University of Pittsburgh in Pennsylvania. 5. Pittsburgh Cancer Institute, University of Pittsburgh in Pennsylvania. 6. Department of Human Genetics, University of Pittsburgh in Pennsylvania.
Abstract
PURPOSE/ OBJECTIVES: To examine the association of the serotonin transport gene and postdischarge nausea and vomiting (PDNV) in women following breast cancer surgery. DESIGN: A cross-sectional study. SETTING: A comprehensive cancer center in Pittsburgh, PA. SAMPLE: 80 post-menopausal women treated surgically for early-stage breast cancer. METHODS: Data were collected using standardized instruments after surgery but before the initiation of chemotherapy. Blood or saliva were used for DNA extraction and analyzed following standardized protocols. Data were analyzed using descriptive statistics and logistic regression. MAIN RESEARCH VARIABLES: Serotonin transport gene (SLC6A4), nausea, vomiting, pain, and anxiety. FINDINGS: Women who inherited the LA/LA genotypes were at greater risk for nausea and vomiting when compared to women who carried any other combination of genotypes. Twenty-one percent of women reported nausea and vomiting an average of one month following surgery and prior to initiation of adjuvant therapy. Those women who experienced PDNV reported significantly higher anxiety and pain scores. CONCLUSIONS: Findings of this study suggest that variability in the genotypes of the serotonin transport gene may help to explain the variability in PDNV in women following breast cancer surgery and why 20%-30% of patients do not respond to antiemetic medications. IMPLICATIONS FOR NURSING: Nurses need to be aware that women who do not experience postoperative nausea and vomiting following surgery for breast cancer continue to be at risk for PDNV long after they have been discharged from the hospital, and this frequently is accompanied by pain and anxiety.
PURPOSE/ OBJECTIVES: To examine the association of the serotonin transport gene and postdischarge nausea and vomiting (PDNV) in women following breast cancer surgery. DESIGN: A cross-sectional study. SETTING: A comprehensive cancer center in Pittsburgh, PA. SAMPLE: 80 post-menopausal women treated surgically for early-stage breast cancer. METHODS: Data were collected using standardized instruments after surgery but before the initiation of chemotherapy. Blood or saliva were used for DNA extraction and analyzed following standardized protocols. Data were analyzed using descriptive statistics and logistic regression. MAIN RESEARCH VARIABLES: Serotonin transport gene (SLC6A4), nausea, vomiting, pain, and anxiety. FINDINGS:Women who inherited the LA/LA genotypes were at greater risk for nausea and vomiting when compared to women who carried any other combination of genotypes. Twenty-one percent of women reported nausea and vomiting an average of one month following surgery and prior to initiation of adjuvant therapy. Those women who experienced PDNV reported significantly higher anxiety and pain scores. CONCLUSIONS: Findings of this study suggest that variability in the genotypes of the serotonin transport gene may help to explain the variability in PDNV in women following breast cancer surgery and why 20%-30% of patients do not respond to antiemetic medications. IMPLICATIONS FOR NURSING: Nurses need to be aware that women who do not experience postoperative nausea and vomiting following surgery for breast cancer continue to be at risk for PDNV long after they have been discharged from the hospital, and this frequently is accompanied by pain and anxiety.
Entities:
Keywords:
breast cancer; genetics; nausea/vomiting
Authors: Ellen L Poleshuck; Jennifer Katz; Carl H Andrus; Laura A Hogan; Beth F Jung; Dale I Kulick; Robert H Dworkin Journal: J Pain Date: 2006-09 Impact factor: 5.820
Authors: Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman Journal: Am J Hum Genet Date: 2006-03-28 Impact factor: 11.025
Authors: Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Bryce B Reeve; Deborah J Bowen; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash; Kathleen E Malone; Patricia A Ganz; Anne McTiernan Journal: Psychooncology Date: 2006-11 Impact factor: 3.894
Authors: Susan W Wesmiller; Susan M Sereika; Catherine M Bender; Dana Bovbjerg; Gretchen Ahrendt; Marguerite Bonaventura; Yvette P Conley Journal: Auton Neurosci Date: 2016-09-28 Impact factor: 3.145
Authors: Sonam Puri; Kelly A Hyland; Kristine Crowe Weiss; Gillian C Bell; Jhanelle E Gray; Richard Kim; Hui-Yi Lin; Aasha I Hoogland; Brian D Gonzalez; Ashley M Nelson; Anita Y Kinney; Stacy M Fischer; Daneng Li; Paul B Jacobsen; Howard L McLeod; Heather S L Jim Journal: Support Care Cancer Date: 2018-03-15 Impact factor: 3.603
Authors: Jong Y Park; Cecile A Lengacher; Richard R Reich; Carissa B Alinat; Sophia Ramesar; Alice Le; Carly L Paterson; Michelle L Pleasant; Hyun Y Park; John Kiluk; Hyo Han; Roohi Ismail-Khan; Kevin E Kip Journal: Transl Behav Med Date: 2019-07-16 Impact factor: 3.626